Try our beta test site
19 studies found for:    kidney disease | mesenchymal stem cells
Show Display Options
Rank Status Study
1 Completed Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells
2 Unknown  Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy
Conditions: Kidney Transplant;   Chronic Allograft Nephropathy
Intervention: Biological: mesenchymal stem cell
3 Completed Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)
Condition: Chronic Kidney Disease
Intervention: Biological: Intravenous injection
4 Recruiting Hypoxia and Inflammatory Injury in Human Renovascular Hypertension
Conditions: Renal Artery Stenosis;   Ischemic Nephropathy;   Renovascular Disease;   Chronic Kidney Disease
Interventions: Drug: Mesenchymal stem cell;   Procedure: Mesenchymal stem cell delivery with stent placement
5 Active, not recruiting MSC for Occlusive Disease of the Kidney
Conditions: Atherosclerotic Renal Artery Stenosis;   Ischemic Nephropathy;   Renovascular Hypertension
Intervention: Drug: Arterial infusion of autologous mesenchymal stem cells
6 Active, not recruiting Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)
Conditions: Renal Insufficiency, Chronic;   Nephrotic Syndrome
Interventions: Drug: Rituximab;   Drug: conventional therapy;   Drug: Mesenchymal stem cells
7 Not yet recruiting Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
Conditions: End Stage Renal Disease (ESRD);   Vascular Access Complication
Intervention: Biological: Adipose Derived Mesenchymal Stem Cells (AMSC)
8 Recruiting Senescence in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Drug: Group 2: Dasatinib;   Drug: Group 2: Quercetin
9 Recruiting Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers
Conditions: Solid Tumors;   Acute Kidney Injury
Intervention: Biological: Mesenchymal stromal cell infusion
10 Unknown  Mesenchymal Stem Cells After Renal or Liver Transplantation
Conditions: Liver Failure;   Kidney Failure
Intervention: Biological: Mesenchymal Stem Cells
11 Not yet recruiting Effect of BM-MSCs in DCD Kidney Transplantation
Conditions: Kidney Transplantation;   Acute Kidney Tubular Necrosis
Interventions: Other: bone marrow-derived mesenchymal stem cells;   Other: Saline;   Drug: Induction therapy (ATG or Basiliximab);   Drug: Maintenance therapy (Low-dose CNI + MPA + steroids)
12 Unknown  Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Biological: mesenchymal stem cell
13 Active, not recruiting Intraportal or Intramuscular Site for Islets in Simultaneous Islet and Kidney Transplantation
Conditions: Type 1 Diabetes;   End Stage Renal Disease
Interventions: Procedure: Intraportal islet transplantation;   Procedure: Intramuscular islet transplantation;   Procedure: Intramuscular transpl with stemcells;   Procedure: Kidney transplantation
14 Unknown  Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Human Umbilical Cord derived MSCs;   Drug: Cyclophosphamide
15 Not yet recruiting Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant.
Conditions: Kidney Transplantation;   Acute Kidney Tubular Necrosis
Interventions: Other: BM-MSCs;   Other: Saline
16 Terminated A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects
Condition: Acute Kidney Injury
Interventions: Biological: AC607;   Biological: Vehicle Only
17 Not yet recruiting A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy
Condition: Acute Kidney Injury
Interventions: Biological: SBI-101;   Device: Sham
18 Enrolling by invitation A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death
Conditions: Disorder Related to Renal Transplantation;   Renal Transplant Rejection
Intervention: Biological: mesenchymal stem cell
19 Completed
Has Results
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Condition: Cancer
Interventions: Drug: Fentanyl sublingual spray;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.